XTalks

NOVEMBER 15, 2022

In Lilly’s case, the fake account claimed the company was giving out free insulin. A fraudulent Eli Lilly account with the username @EliLillyandCo tweeted a message on November 10 that said: “We are excited to announce insulin is free now.”. On average, it is estimated that insulin costs about $98.70 percent, or by $16.08

Insulin 90

Insulin Sales Branding Production 90

XTalks

AUGUST 13, 2024

Abbott and Medtronic have struck a global partnership to make diabetes management easier for people who need regular insulin injections. Abbott’s CGM sensors will work with Medtronic’s AID algorithms to automatically adjust insulin levels based on real-time blood sugar readings. billion by 2033.

Insulin 52

Insulin FDA Approval Marketing Development 52

XTalks

OCTOBER 8, 2021

Medtronic has expanded a Class I recall of remote controllers used with the MiniMed 508 insulin pump or the MiniMed Paradigm family of insulin pumps over potential cybersecurity risks. The medtech giant has also expanded another Class I recall of the retainer rings on its 600 series insulin pumps.

Insulin 128

Insulin Life Science Drugs Regulation 128

XTalks

JULY 3, 2023

The treatment is derived from deceased donor pancreatic cells and is indicated for patients who are unable to achieve average blood glucose levels (glycated hemoglobin) with daily insulin injections or with continuous infusion through a pump because of repeated episodes of severe hypoglycemia (low blood sugar).

Insulin 96

Insulin Gene Therapy Gene Regulation 96

XTalks

SEPTEMBER 14, 2022

Ayesha also talked about Medtronic’s new partnership with former Disney star Jennifer Stone on a new ad campaign for its diabetes tech, including the smart insulin injector InPen. Subscribe to the Xtalks Life Science Podcast to never miss a new episode. Hear more about the rare, fatal disease and the new drug approval for it.

Life Science 71

Life Science FDA Approval Insulin Drugs 71

XTalks

JULY 27, 2022

Toleikis spoke about the latest clinical trial data for the medical device, and also about the company’s new partnership with Evotec to integrate its insulin-producing cells in the Cell Pouch System. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 52

Life Science Insulin Clinical Trials Clinical Trials 52

BioTech 365

JUNE 16, 2021

Amalgam Rx™ Receives CE Mark for Basal Insulin Titration Amalgam Rx™ Receives CE Mark for Basal Insulin Titration Insulin Titration App Meets Requirements for European Launch WILMINGTON, Del.–(BUSINESS the leader in connecting healthcare providers and life sciences … Continue reading →

Insulin 40

Insulin Life Science 40

XTalks

OCTOBER 28, 2024

Diabetes, a chronic condition marked by high blood glucose levels due to insulin issues, brings complications like heart disease, stroke, neuropathy and diabetic foot ulcers. Abbot also joined Medtronic to pair its sensors with the latter’s automated insulin delivery (AID) systems. million undiagnosed and 115.9

Insulin 104

Insulin FDA Approval Marketing Doctors 104

XTalks

FEBRUARY 2, 2023

The US Food and Drug Administration (FDA) has recently cleared for marketing an app called Tidepool Loop which can be used with compatible devices for automated insulin dosing (AID). The Tidepool loop app involves three integral parts: an integrated continuous glucose monitor (iCGM), a controller and an insulin pump.

Insulin 52

Insulin Marketing Life Science Development 52

XTalks

NOVEMBER 23, 2022

Subscribe to the Xtalks Life Science Podcast to never miss a new episode. Pfizer Shares Positive Phase III Data for Maternal RSV Vaccine Candidate. The weekly podcast is available for streaming every Wednesday on Spotify , Apple Music and wherever you stream your podcasts.

Life Science 52

Life Science FDA Approval Vaccination Vaccine 52

Pharmaceutical Technology

FEBRUARY 16, 2023

Despite such a broad range of pathologies, the commonality between them is the insulin response. dietary restriction) of the evolutionarily conserved insulin signalling pathway. Can we extend human life? These experiments demonstrated that the linkage between ageing and insulin was conserved up the evolutionary tree.

Insulin 130

Insulin DNA Genetics Life Science 130

XTalks

JULY 15, 2024

Congenital HI is a genetic disorder that causes excessive insulin production by the pancreas, which lowers plasma or blood sugar. Agonist engagement of the receptor is involved in insulin and glucose regulation, and hence has therapeutic implications for diseases like diabetes and obesity.

Drugs 52

Drugs Insulin Life Science Marketing 52

XTalks

JULY 15, 2024

Congenital HI is a genetic disorder that causes excessive insulin production by the pancreas, which lowers plasma or blood sugar. Agonist engagement of the receptor is involved in insulin and glucose regulation, and hence has therapeutic implications for diseases like diabetes and obesity.

Insulin 52

Insulin Drugs Life Science Marketing 52

XTalks

MARCH 15, 2024

The drugs include Lilly’s newly approved GLP-1 obesity drug Zepbound (tirzepatide), around a dozen of the company’s insulins and migraine drug Emgality (galcanezumab). It is estimated that more than 8 million Americans rely on insulin products to manage their diabetes.

Pharmacy 110

Pharmacy Drugs Insulin Branding 110

XTalks

SEPTEMBER 13, 2022

Med tech giant Medtronic is teaming up with Disney Channel’s “Wizards of Waverly Place” actress Jennifer Stone to promote its reusable smart insulin injectable InPen. The InPen system helps patients take the correct amount of insulin at the right time. The show ran from 2007 to 2012.

Insulin 85

Insulin Nurses Life Science Production 85

BioTech 365

JUNE 16, 2021

Amalgam Rx™ and Novo Nordisk® Plan Global Expansion Amalgam Rx™ and Novo Nordisk® Plan Global Expansion Insulin Titration App, Dose Check®, to Reach Patients Worldwide WILMINGTON, Del.–(BUSINESS the leader in connecting healthcare providers and life sciences companies … Continue reading →

Insulin 40

Insulin Life Science 40

Scienmag

JANUARY 22, 2021

A new mechanism that underlies insulin resistance and type 2 diabetes In a new study published in Journal of Extracellular Vesicles, Chen-Yu Zhang’s group at Nanjing University, School of Life Sciences, and Antonio Vidal-Puig’s group at University of Cambridge report that pancreatic ?

Insulin 40

Insulin Life Science 40

XTalks

NOVEMBER 22, 2022

Type 1 diabetes, also known as insulin-dependent or juvenile diabetes, is an autoimmune disease that occurs when the body is unable to make enough insulin due to destruction of the beta insulin-producing cells in the pancreas. In the US, it is estimated that 1.45 million people are currently living with type 1 diabetes.

Insulin 89

Insulin Drugs FDA Approval Immune Response 89

XTalks

JANUARY 16, 2023

The body becomes resistant to insulin and can no longer use glucose properly as a fuel, so glucose begins circulating in the bloodstream and may lead to problems with the circulatory, nervous and immune systems. Often, diabetes medication or insulin therapy are used as management tools.

Insulin 77

Insulin Regulation Development Drugs 77

XTalks

JUNE 3, 2021

The study , published yesterday in the Endocrine Society’s Journal of Clinical Endocrinology and Metabolism , revealed that two helpings of fruit led to higher measures of insulin sensitivity than those who ate less than half a serving. Diabetes is a growing health problem globally. Keep it Fresh.

Insulin 53

Insulin Development Research Doctors 53

XTalks

SEPTEMBER 15, 2020

In addition to the vaccine, the company is also developing an investigational drug called Remygen for the regeneration of endogenous insulin production and to improve hormonal response to hypoglycemia; trials to test the treatment are currently ongoing in patients that have been living with type 1 diabetes for more than five years.

Vaccination 83

Vaccination Vaccine Insulin Trials 83

XTalks

JUNE 14, 2024

Ontario, Canada’s largest province by population, is stepping up its commitment to the life sciences sector with an investment of $40 million. The $40 million will come from the Venture Ontario Fund, which is dedicated to helping Ontario life sciences companies and biomanufacturers innovate, grow and compete in global markets.

Life Science 52

Life Science Insulin Research Manufacturing 52

XTalks

FEBRUARY 9, 2021

While type 2 diabetes is associated with inflammation, which could potentially explain the link between a COVID-19 infection and ensuing inflammatory response, the reasons for the onset of insulin-dependent type I diabetes is a bit less clear.

Insulin 105

Insulin Immune Response Hormones Research 105

XTalks

NOVEMBER 9, 2022

GLP-1 receptor agonists, or incretin (metabolic hormones) mimetics, are analogs of the GLP-1 peptide hormone that binds to the GLP-1 receptor to regulate blood sugar levels by boosting insulin secretion. dependent insulin secretion and suppression of glucagon release. mediated glucose?dependent

Insulin 98

Insulin Hormones FDA Approval Sales 98

XTalks

JUNE 10, 2024

The study explored efruxifermin’s potential in reducing liver fat, reversing fibrosis, enhancing insulin sensitivity and improving lipid profiles, representing a comprehensive treatment strategy for MASH. It not only reduces liver fat and inflammation but can also reverse fibrosis, enhance insulin sensitivity and improve lipid profiles.

Insulin 52

Insulin Life Science Regulation Hormones 52

XTalks

NOVEMBER 21, 2024

These gut hormones are released in response to nutrient intake and play a crucial role in the incretin effect, which enhances insulin secretion. It’s the first and only approved dual agonist targeting both the GIP and GLP-1 receptors. Researchers monitored a range of health metrics, including fasting glucose, HbA1c levels and weight changes.

Sales 103

Sales Insulin Drugs Trials 103

XTalks

MARCH 8, 2021

GLP-1 receptor agonists lower blood glucose levels by increasing the production of insulin. GLP-1 receptor agonists mimic the action of GLP-1, an intestinal hormone that stimulates the secretion of insulin when blood glucose levels rise. GLP-1 acts on GLP-1 receptors on insulin-producing pancreatic ? GLP-1 Receptor Agonists.

Insulin 98

Insulin Hormones Clinical Trials Clinical Trials 98

XTalks

DECEMBER 14, 2022

CGMs can alert diabetics sufficiently in advance of too high or low blood glucose levels, allowing the wearer to improve the situation with insulin, for example. The CGM can be integrated with insulin delivery systems and connected to devices like Apple watches and popular health apps. Dexcom, Inc. , a cellphone) every five minutes.

Insulin 98

Insulin Marketing Branding Life Science 98

Pharmaceutical Technology

DECEMBER 22, 2022

The company has partnered with life sciences-focused investors Sixth Street and Royalty Pharma with an aim to bring substantial non-dilutive, low-cost capital to boost innovation and growth. Blueprint Medicines wins the Financing award this year after securing significant financing partnerships worth up to $1.25bn. Civica JAAQ Sanofi.

Insulin 130

Insulin Production Development Genetics 130

XTalks

JULY 17, 2024

Octreotide is a synthetic analog of somatostatin, a hormone in the body that inhibits the release of several other hormones, including growth hormone (GH), glucagon and insulin. Excess GH stimulates the secretion of insulin-like growth factor-1 (IGF-1) from the liver, which causes most of the clinical manifestations of acromegaly.

Trials 59

Trials Hormones Clinical Trials Clinical Trials 59

XTalks

JANUARY 25, 2023

XTALKS WEBINAR: Review of Key Trends for Life Science Commercial Teams in 2023 Register for this free on-demand webinar to learn about the latest trends in sales and marketing campaigns that could help bolster commercial success for life science companies this year.

FDA Approval 52

FDA Approval Drugs Life Science Cosmetics 52

XTalks

OCTOBER 26, 2020

Autoantibody screening involves measuring levels of islet autoantibodies (iAb) that recognize antigens found in insulin-producing pancreatic beta cells. The presence of one or more iAbs indicates pancreatic autoimmunity and is consistent with a T1D diagnosis.

Insulin 98

Insulin Packaging Packaging Doctors 98

XTalks

NOVEMBER 27, 2024

billion) insulin manufacturing facility at its Frankfurt Höchst campus in Germany. At the same time, Sanofi budgeted €100 million ($108 million) to expand its Le Trait facility in Normandy, which produces the anti-inflammatory blockbuster Dupixent (dupilumab). It also allotted €10 million ($10.8 In August, Sanofi unveiled plans for a €1.3

Production 52

Production Manufacturing Drugs Antibody 52

XTalks

FEBRUARY 8, 2021

Last year, Biocon Biologics and Mylan announced they’d be seeking interchangeable status for their long-acting insulin product Semglee , developed to be an alternative to Sanofi’s Lantus (insulin glargine). This includes information on approved indications and risk statements applicable to both the biosimilar and its reference product.

Production 58

Production Insulin Branding Generic Drugs 58

Pharmaceutical Technology

JANUARY 31, 2023

Inflation Reduction Act Speaking during the keynote panel “FDA & ARPA-H: Life Sciences, Biopharma & Medtech Priorities in a New Year”, Califf discussed the Inflation Reduction Act of August 2022, which aims to lower prescription drug prices.

Drugs 130

Drugs Regulation Gene Therapy Insulin 130

Pharmaceutical Technology

AUGUST 15, 2022

It is no secret that Canada boasts a strong and competitive life sciences sector. The country has a long history of leadership and innovation in this field, from the discovery of stem cells and insulin to the invention of the world’s first pacemaker and much more. Canada’s next life sciences leader.

Life Science 130

Life Science Research Manufacturing Insulin 130

XTalks

OCTOBER 22, 2021

In July 2021, the agency approved the first interchangeable biosimilar product, Semglee (insulin glargine-yfgn) for the treatment of diabetes. Semglee is both biosimilar to, and interchangeable with, Lantus (insulin glargine).

FDA Approval 97

FDA Approval Production Insulin Antibody 97